INFORMATION BY CANCER TYPE

Ovarian

Drug Conjugate Tested in Resistant Ovarian Cancer
BY Ariela Katz
The investigational compound targets overexpressed folate receptor-alpha.
Ending a Dry Spell of Years Without Treatment for Ovarian Cancer
BY Jessica D’Amico
After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.
Looking Ahead: Robotic Surgery for Gynecologic Cancers
BY Danielle Bucco
Shana Wingo, M.D., discussed advancements being made in the field of surgery for patients with gynecologic cancers.
Can Hypertension Improve Ovarian Cancer Survival?
BY Brielle Urciuoli
A recent study examined common co-morbidities, such as diabetes, heart disease and hypertension, and their effects on ovarian cancer survival.
Expert Discusses Surgery's Evolving Role in Ovarian Cancer
BY Gina Columbus
Shana Wingo, M.D., discusses surgery's changing role in the treatment of ovarian cancer.
PARP Inhibitors Continue to Change Ovarian Cancer Treatment
BY Angelica Welch
PARP inhibitors like Rubraca and Lynparza continue to shape the treatment landscape of ovarian cancer. 
Zejula Granted FDA Approval for Ovarian Cancer
BY Jason M. Broderick
The FDA has approved Zejula (niraparib) for treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in the maintence setting. 
New Trial Suggests Maintenance Chemotherapy Does Not Aid Overall Survival
Results from a randomized trial suggest maintenance chemotherapy after debulking surgery and adjuvant platinum-based chemotherapy do not improve overall survival rates among women with ovarian cancer who had achieved remission.
Hormonal Maintenance Therapy Improves Progression-Free Survival in Ovarian Cancer
BY Danielle Bucco
Hormonal maintenance therapy may be able to improve PFS rates for some patients with ovarian cancer, according to a recent study.
Lynparza Improves Progression-Free Survival in BRCA+ Ovarian Cancer
Patients with BRCA-mutant ovarian cancer saw an improved progression-free survival with Lynparza, according to a recent study.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Ovarian CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Ovarian Epithelial Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial cancer.
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment.
Ovarian Germ Cell Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian germ cell tumors.
Ovarian Low Malignant Potential Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Ovarian Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing ovarian cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Ovarian Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for ovarian cancer.
x